Emily C L Wong

机构：University of California, Los Angeles, UCLA Health, Population Health Research Institute, Institut de Recherche en Santé Digestive, McMaster University · ORCID：0000-0001-9472-201X

发表论文 113 篇 · 总被引 1356 次 · h-index 19

代表论文

Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression (2024 · Clinical Gastroenterology and Hepatology · 被引 21)
Impact of diet on inflammatory bowel disease risk: systematic review, meta-analyses and implications for prevention (2025 · EClinicalMedicine · 被引 10)
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease (2024 · Journal of Crohn s and Colitis · 被引 9)
Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis (2024 · Journal of Crohn s and Colitis · 被引 8)
Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease (2025 · Journal of Crohn s and Colitis · 被引 7)
Use of Modified Multiplier of the Simple Endoscopic Score for Crohn’s Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial (2024 · Journal of Crohn s and Colitis · 被引 4)